Funding for Medical Research
and Clinical Trials
and Clinical Trials
Funding Details for Cancer
Use the contact information shown for the organization to apply for the funding.
Please notify CenTrial of any offer is incorrect or has expired.
Please notify CenTrial of any offer is incorrect or has expired.
Lymphoma
Lymphoma Research Foundation
Type of Organization: Foundation
Email Address: researchgrants@lymphoma.org
Funds Available for Clinical Trials: ✗ Research: ✔
institution in the U.S. or Canada. Applicant must be from an ACGME accredited specialty
(e.g., hematology/oncology, pediatrics, pathology, dermatology, radiation oncology).
2 Applicant is an advanced fellow (at least 24 months of fellowship training) or junior faculty
member with no greater than 6 years of experience beyond completion of their fellowship
or postdoctoral training as of March 1, 2024. (The six-year limit may be non-sequential in
case of pregnancy or illness.)
3 Applicant’s project involves clinical research in lymphoma and/or chronic lymphocytic
leukemia and does not include other hematologic malignancies or cancers. The project
should contribute to the development or assessment of therapies or diagnostic tools.
Translational and/or laboratory research components are permitted as long as they are
not the primary focus of the project.
4 Applicant may not simultaneously receive another career development award (such as NIH
K-series awards or equivalent). Refer to page 2 of the RFP for full details on these
restrictions.
5 Applicant will spend 35 to 50 percent of their time in research as opposed to patient care,
teaching, or administrative responsibilities.
6 Applicant has a primary mentor at their institution, who will oversee the applicant’s
research training.
7 Applicant is primarily responsible for the design, protocol writing, IRB submission, conduct,
analysis and publication of one or more clinical trials during the award period.
Other info: The Lymphoma Research Foundation (LRF) maintains a strong commitment to supporting early career investigators
and ensuring they can build a successful career in the field of lymphoma research. The LRF Clinical Investigator Career
Development Award (CDA) Program is designed to support physician investigators at the level of advanced fellow or
junior faculty member who will contribute to the development of new lymphoma therapies and diagnostic tools.
Eligible investigators must have no greater than five years of experience beyond completion of their fellowship or postdoctoral training (the five-year limit may be non-sequential in cases of pregnancy or illness).
The goal of the program is to prepare physician investigators to design and administer clinical research studies in
lymphoma and assume primary responsibilities for clinical research, protocol writing, Institutional Review Board (IRB)
submission and publication. As such, a Career Development Plan is required as part of the Grant Application. The
proposed research plan should also develop the necessary knowledge and clinical research skills relevant to the
investigator’s career goals. The Grant is designed to provide physician investigators with support to spend 35-50
percent of their time implementing clinical research studies in lymphoma.
Lymphoma Research Foundation
Type of Organization: Foundation
Email Address: researchgrants@lymphoma.org
Funds Available for Clinical Trials: ✗ Research: ✔
Funding Details
Requirements: 1 Applicant is a licensed clinical physician (MD, MD/PhD, DO or equivalent) at a researchinstitution in the U.S. or Canada. Applicant must be from an ACGME accredited specialty
(e.g., hematology/oncology, pediatrics, pathology, dermatology, radiation oncology).
2 Applicant is an advanced fellow (at least 24 months of fellowship training) or junior faculty
member with no greater than 6 years of experience beyond completion of their fellowship
or postdoctoral training as of March 1, 2024. (The six-year limit may be non-sequential in
case of pregnancy or illness.)
3 Applicant’s project involves clinical research in lymphoma and/or chronic lymphocytic
leukemia and does not include other hematologic malignancies or cancers. The project
should contribute to the development or assessment of therapies or diagnostic tools.
Translational and/or laboratory research components are permitted as long as they are
not the primary focus of the project.
4 Applicant may not simultaneously receive another career development award (such as NIH
K-series awards or equivalent). Refer to page 2 of the RFP for full details on these
restrictions.
5 Applicant will spend 35 to 50 percent of their time in research as opposed to patient care,
teaching, or administrative responsibilities.
6 Applicant has a primary mentor at their institution, who will oversee the applicant’s
research training.
7 Applicant is primarily responsible for the design, protocol writing, IRB submission, conduct,
analysis and publication of one or more clinical trials during the award period.
Other info: The Lymphoma Research Foundation (LRF) maintains a strong commitment to supporting early career investigators
and ensuring they can build a successful career in the field of lymphoma research. The LRF Clinical Investigator Career
Development Award (CDA) Program is designed to support physician investigators at the level of advanced fellow or
junior faculty member who will contribute to the development of new lymphoma therapies and diagnostic tools.
Eligible investigators must have no greater than five years of experience beyond completion of their fellowship or postdoctoral training (the five-year limit may be non-sequential in cases of pregnancy or illness).
The goal of the program is to prepare physician investigators to design and administer clinical research studies in
lymphoma and assume primary responsibilities for clinical research, protocol writing, Institutional Review Board (IRB)
submission and publication. As such, a Career Development Plan is required as part of the Grant Application. The
proposed research plan should also develop the necessary knowledge and clinical research skills relevant to the
investigator’s career goals. The Grant is designed to provide physician investigators with support to spend 35-50
percent of their time implementing clinical research studies in lymphoma.